Clear Search sequence regions


  • acetyl coa (1)
  • analysis data (2)
  • analysis factors (1)
  • apoptosis (1)
  • b 14 (1)
  • blood (1)
  • brazil (1)
  • calcineurin (2)
  • cardiovascular diseases (1)
  • caroli disease (1)
  • case (2)
  • cholesterol (3)
  • cholesterol hdl (1)
  • cholesterol levels (1)
  • ciclosporin (3)
  • cirrhosis alcohol (12)
  • corticosteroids (6)
  • current smoker (2)
  • cytokines (1)
  • diagnosis (5)
  • disease risk (2)
  • disease wilson (2)
  • donor (3)
  • essential (2)
  • everolimus (3)
  • factor cols (2)
  • factors (4)
  • fast (2)
  • fibers (1)
  • gluconeogenesis (1)
  • GLUT2 (1)
  • GLUT4 (1)
  • glycogen (1)
  • graft (3)
  • hemochromatosis (1)
  • hepatocellular carcinoma (7)
  • hormones (1)
  • hyperglycemia (4)
  • hypertriglyceridemia (7)
  • immunosuppressants (3)
  • impaired (5)
  • incretin (1)
  • insulin (15)
  • ldl (2)
  • ldl cholesterol (2)
  • lipid (2)
  • liver (19)
  • liver cirrhosis (2)
  • liver disease (3)
  • liver failure (4)
  • liver steatosis (3)
  • liver transplant (21)
  • lymphocytes (1)
  • manner (1)
  • mass (2)
  • men (1)
  • meta analysis (2)
  • mortality (1)
  • necrosis (1)
  • odds ratio (4)
  • patients (182)
  • patients care (1)
  • period (2)
  • plasma (1)
  • problems (1)
  • protocol (1)
  • reason (2)
  • receptors (2)
  • renal function (2)
  • research (4)
  • research ethics committee (1)
  • risk factors (30)
  • screen (1)
  • serum (2)
  • sex (1)
  • sirolimus (4)
  • skeletal muscle (2)
  • smoking (3)
  • statin (1)
  • status (1)
  • suggest (2)
  • t cell (1)
  • tacrolimus (14)
  • TNF α (1)
  • transplant (146)
  • transplant liver (1)
  • tumor size (1)
  • urea (1)
  • weight (2)
  • weight height (1)
  • χ2 test (1)
  • Sizes of these terms reflect their relevance to your search.

    Post-transplant diabetes mellitus (PTDM) is a common metabolic complication after liver transplant that negatively affects a recipient's survival and graft function. This study aims to identify risk factors associated with diabetes after liver transplant. This is a cross-sectional study conducted from September to November 2019. Data collection was performed by chart review, and patients were divided into 3 groups: patients without diabetes mellitus (DM), patients with pre-transplant diabetes mellitus, and patients with PTDM. Two hundred and forty-seven patients' medical charts were screened, and 207 patients were included: 107 without DM, 42 with pre-transplant DM, and 58 with PTDM. The leading cause for liver transplant was hepatitis C, followed by hepatocellular carcinoma secondary to alcohol. There was a higher exposure to tacrolimus in patients without DM (P = 0.02) and to ciclosporin in patients with pre-transplant DM, compared to others (P = 0.005). Microscopic interface inflammatory activity was more severe in patients without DM as well as those with PTDM (P = 0.032). There was a higher prevalence of steatosis in recipients with pre-transplant DM than there was in others (P < 0.001). Multivariate logistic regression identified the following independent risk factors for DM: cirrhosis due to alcohol, hepatitis C, and triglycerides. For PTDM, these independent risk factors were cirrhosis due to alcohol, hepatitis C, and prednisone exposure. Alcoholic cirrhosis is a risk factor for PTDM in liver recipients. Liver transplant recipients with a pre-transplant history of cirrhosis due to alcohol, hepatitis C, and prednisone exposure deserve more caution during PTDM screening.

    Citation

    Mariana Baldini Campos, Cínthia Minatel Riguetto, Ilka de Fátima Santana Ferreira Boin, Arnaldo Moura. Risk factors associated with diabetes after liver transplant. Archives of endocrinology and metabolism. 2022 Mar 23;66(2):182-190

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35315984

    View Full Text